A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19
Clinical trial NCT04868890 · TERMINATED
Trial details
- NCT number
- NCT04868890
- Sponsor
- Ampio Pharmaceuticals. Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2022-02-16
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.